Skip to main content
. 2023 Apr 12;21(5):1117–1138. doi: 10.2174/1570159X20666220915092703

Table 1.

Mitochondria based therapeutic interventions of ALS along with their molecular mechanism and disease conditions.

S. No. Interventions Structure Mechanism Disease Condition References
1 Exercise or
Aerobic endurance
graphic file with name CN-21-1117-t1-1.jpg Mitochondrial biogenesis and increased muscle mitochondrial enzyme activities and muscle strength ALS: Mitochondrial Diseases like Mitochondrial myopathy in ALS and other indications [119-123]
2 Riluzole graphic file with name CN-21-1117-t1-2.jpg Diminishes the ROS generation via anti-glutamatergic effects tendency and attenuates inward calcium current ALS: Maintaining mitochondrial calcium buffering mechanisms in ALS [112, 113]
3 Edaravone graphic file with name CN-21-1117-t1-3.jpg Neuro-protective effect by boosting prostacyclin production, reducing lipoxygenase metabolism of arachidonic acid by blocking hydroxyl radicals, preventing alloxan-induced lipid peroxidation and quenching active oxygen species ALS: Free radical scavenger and antioxidant in ALS [115]
4 Fenofibrate graphic file with name CN-21-1117-t1-4.jpg PPAR-α activation ALS: Neuroinflammation and mitochondrial dysfunction in ALS [124]
5 Vitamins C (Ascorbic Acid) graphic file with name CN-21-1117-t1-5.jpg Endogenous defensive strategy against oxygen free radicals in mitochondria Protection against lipoperoxidation ALS: Electron carrier and
Antioxidant in ALS
[125]
6 Vitamin E
(α-tocopherol)
graphic file with name CN-21-1117-t1-6.jpg Protection against lipoperoxidation ALS: Lipophilic antioxidant has the ability to cross cell membrane resulting in delay and lower risk of clinical onset in ALS
Decrease in plasma levels of thiobarbituric acid reactive species
[126, 127]
7 Co-enzyme Q10 (CoQ10) graphic file with name CN-21-1117-t1-7.jpg A strong lipid oxidants scavenger, which participates in transferring electrons from mitochondrial complexes I and II to mitochondrial complex III.
CoQ10: stabilizes mitochondrial membrane potential, prevents cytochrome c release; inhibits mitochondrial permeability transition pore, and blocks.
Bax translocation to mitochondria
ALS: Stabilized the motor neuron function in neuro-degenerative disorders like ALS and other indications [128-131]
8 Glutathione (GSH) graphic file with name CN-21-1117-t1-8.jpg Antioxidant property: Neuronal GSH helps in the protection of neurons in the brain against ROS and oxidative
damage
ALS: Regulates the development and progression of Amyotrophic Lateral Sclerosis [132]
9 Resveratrol graphic file with name CN-21-1117-t1-9.jpg Inhibits mutant SOD1 (G93A) protein, up-regulates SIRT1, down-regulates AMPK/SIRT1 signalling and activates mitochondrial biogenesis ALS: Improves muscle atrophy and mitochondrial dysfunction in ALS and other indications [133-135]
10 β-carotene graphic file with name CN-21-1117-t1-10.jpg Antioxidant properties ALS: Neuroinflammation and apoptosis in ALS. [136]
11 7,8-Dihydroxy-flavone (7,8-DHF) graphic file with name CN-21-1117-t1-11.jpg Modulates metabolic pathways and Improves motor deficits and enhances lower neuronal survival ALS: Chronic administration of 7,8-DHF improved motor deficits in ALS [137]
12 Epigallocatechin Gallate graphic file with name CN-21-1117-t1-12.jpg Protection against
Lipoperoxidation, diminishes the level of NF-kB, caspase-3 and iNOS
ALS: Delays the advancement of ALS by alterations in intracellular signals, enhances survival signals (like PI3-K and Akt) and lowers death signals (like GKS-3ß, cytosolic cytochrome c, activated caspase3 and cleaved poly ADP-ribose polymerase) in ALS and other indications [138-140]
13 Curcumin graphic file with name CN-21-1117-t1-13.jpg Activates Nrf2, reduces intra-cellular ROS levels, and eradicates excitability induced by TDP-43 ALS: Decreases ALS progression by reducing oxidative damage and improves survival, especially in bulbar onset patients [140, 141]
14 Melatonin graphic file with name CN-21-1117-t1-14.jpg Antioxidant effect regulates mitochondrial dysfunction and bioenergetic function ALS: Orally high doses delayed ALS progression via caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and increases the survival rate [141-143]
15 SBT-272 NA Novel peptidomimetic, a role in mitochondrial energetics, by increasing ATP production and decreasing levels of reactive oxygen species (ROS) in dysfunctional mitochondria Amyotrophic lateral sclerosis (ALS) Stealth BioTherapeutics
16 MitoQ - Accumulates within mitochondria and protects it from oxidative damage ALS: slowed the mitochondrial functional decline in the spinal cord and muscle; decreased nitroxidative damage in the nervous system; increased survival and slowed the progression of ALS symptoms. [144]
17 Albrioza - Reduces neuronal death by blocking key cellular death pathways of
mitochondria and endoplasmic
reticulum
ALS: neuronal protection [116-118]